PeptideStack
5.2kquestions
20kanswers
220users

Is 2.5 mg in 3 mL of 0.9% sodium chloride a sensible presentation for cagrilintide?

Asked 1 May 2024Modified 2.2 years agoViewed 24k times
20

The case in front of me: 2.5 mg · 3 mL · 0.9% sodium chloride · cagrilintide.

The failure mode I am trying to avoid is making this decision emotionally.

I have twelve months in view and I would like the plan to survive that long.

What should I decide now, and what should I defer?

diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

308 questionsreconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

330 questionsdosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

811 questions
shareeditfollowflag
SN
askedsyringe_ninety15k281 May 2024
2This is the answer I was looking for three months ago. – triple_agonist_q 4 months ago
3The arithmetic checks out. I ran the same numbers and got the same result. – sian_llewellyn 5 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 24k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.